NUCLEAR LOCALIZATION OF IMPDH2, THE PRIMARY TARGET OF MYCOPHENOLIC ACID, CONSTRAINS HEPATOCELLULAR CARCINOMA

被引:0
|
作者
Chen, K. [1 ,2 ]
Sideras, K. [1 ]
Ma, B. [1 ]
Cao, W. [1 ]
van der Laan, L. J. [3 ]
Sprengers, D. [1 ]
Smits, R. [1 ]
Metselaar, H. J. [1 ]
Kwekkeboom, J. [1 ]
Peppelenbosch, M. P. [1 ]
Pan, Q. [1 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China
[3] Erasmus MC Univ Med Ctr, Dept Surg, Rotterdam, Netherlands
关键词
D O I
10.1016/S0168-8278(16)01028-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-059
引用
收藏
页码:S567 / S567
页数:1
相关论文
共 50 条
  • [1] IMPDH2-TARGETED CONSTRAINT OF CELL GROWTH IN HEPATOCELLULAR CARCINOMA BY MYCOPHENOLIC ACID
    Chen, K.
    Man, K.
    Metselaar, H. J.
    Janssen, H. L. A.
    Kwekkeboom, J.
    Sprengers, D.
    Bruno, M. J.
    Peppelenbosch, M. P.
    Pan, Q.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S88 - S88
  • [2] IMPDH2-targeted Constraint of Cell Growth in Hepatocellular Carcinoma by Mycophenolic Acid
    Chen, Kan
    Man, Kwan
    Metselaar, Herold J.
    Janssen, Harry L. A.
    Kwekkeboom, Jaap
    Sprengers, Dave
    Bruno, Marco J.
    Peppelenbosch, Maikel P.
    Pan, Qiuwei
    LIVER TRANSPLANTATION, 2014, 20 : S256 - S256
  • [3] IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex
    Pua, Khian Hong
    Stiles, Dylan T.
    Sowa, Mathew E.
    Verdine, Gregory L.
    CELL REPORTS, 2017, 18 (02): : 432 - 442
  • [4] IMPDH2 and mycophenolic acid:: Effect of a novel SNP on enzyme activity and leukopenia in transplant patients.
    Wang, J.
    Zeevi, A.
    Webber, S.
    Gimita, M.
    Selby, R.
    Sher, L.
    Fu, J.
    Phougsamran, P.
    Pravica, V.
    Hutchinson, I. V.
    Burckart, G. J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1088 - 1088
  • [5] Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics
    Wu, T-Y
    Peng, Y.
    Pelleymounter, L. L.
    Moon, I.
    Eckloff, B. W.
    Wieben, E. D.
    Yee, V. C.
    Weinshilboum, R. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) : 1584 - 1598
  • [6] USP5 deubiquitinates and stabilizes IMPDH2, to promote hepatocellular carcinoma progression
    Jiang, Shuoyi
    Jiang, Liyang
    Xu, Yingying
    Ma, Yunju
    Deng, Yiran
    Jiao, Can
    Yin, Min
    Qin, Chao
    Li, Jiale
    Zhang, Li
    Chen, She
    ONCOGENE, 2025,
  • [7] Over-expression of IMPDH2 is associated with tumor progression and poor prognosis in hepatocellular carcinoma
    He, Ying
    Zheng, Zhousan
    Xu, Yi
    Weng, Huiwen
    Gao, Ying
    Qin, Kai
    Rong, Jian
    Chen, Cui
    Yun, Miao
    Zhang, Jiaxing
    Ye, Sheng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (08): : 1604 - 1614
  • [8] High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma
    Xu, Yi
    Zheng, Zhousan
    Gao, Ying
    Duan, Shiyu
    Chen, Cui
    Rong, Jian
    Wang, Kebing
    Yun, Miao
    Weng, Huiwen
    Ye, Sheng
    Zhang, Jiaxing
    SCIENTIFIC REPORTS, 2017, 7
  • [9] High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma
    Yi Xu
    Zhousan Zheng
    Ying Gao
    Shiyu Duan
    Cui Chen
    Jian Rong
    Kebing Wang
    Miao Yun
    Huiwen Weng
    Sheng Ye
    Jiaxing Zhang
    Scientific Reports, 7
  • [10] Induction of IMPDH2 are required for EBV-driven transformation of primary B cells
    Sugimoto, Atsuko
    Murata, Takayuki
    CANCER SCIENCE, 2023, 114 : 522 - 522